Description: Biotech Acquisition Company is a blank check company. The Company is created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. The Company focuses for a target business in the healthcare sector. It has no operations and has no revenues.
545 West 25th Street
New York,
NY
10001
United States
Phone:
212 227 1905
Officers
| Name | Title |
|---|---|
| Dr. Michael Shleifer Ph.D. | Chairman & CEO |
| Mr. Thomas Fratacci | CFO & Treasurer |
| Mr. Ivan Jarry | Chief Operating Officer |
| Mr. Albert F. Hummel M.B.A. | Chief Investment Officer & Director |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 38.9808 |
| Price-to-Book MRQ: | 1.3283 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2021-03-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |